Company: IPST
Filing Date: 2025-10-16
Form Type: S-1/A
Source: 0001213900-25-099309
Chunk: 350

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-10-16
Form: S-1/A
Chunk 350
---
— On April 14, 2025, the Company received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the Company’s closing bid price for its common stock was below $ 1.00per share for the prior thirty ( 30) consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company had been granted a 180 -calendarday compliance period, or until October 13, 2025, to regain compliance with the Minimum Bid Price Requirement. On October10, 2025, the Company submitted a formal request to Nasdaq for an additional 180 -calendarday period to regain compliance with the Minimum Bid Price Requirement and provided written notice to Nasdaq that it intends to effectuate a reverse stock split during the additional compliance period if necessary to regain compliance with the Minimum Bid Price Requirement. On October14, 2025, the Company received a letter from Nasdaq notifying F-38 Heritage Distilling Holding Company, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited) NOTE 10 — COMMITMENTS AND CONTINGENCIES (cont.) it that it was eligible for an additional 180 -calendarday period, or until April13, 2026 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Requirement. During the Compliance Period, the Company’s shares of Common Stock will continue to be listed and traded on the Nasdaq Capital Market. If at any time during the Compliance Period, the bid price of the Common Stock closes at or above $ 1.00per share for a minimum of ten ( 10) consecutive business days, Nasdaq will provide the Company with written confirmation of compliance with the Minimum Bid Price Requirement and the matter will be closed. If the Company does not regain compliance within the Compliance Period, including any additional extensions that may be granted by Nasdaq, or if it appears to Nasdaq’s staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Common Stock will be subject to delisting from the Nasdaq Capital Market. At that time, the Company may appeal any such delisting determination to a Nasdaq hearings panel. The Company intends to continuously monitor the closing bid price for its Common Stock